BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15963182)

  • 21. Pediatric quality of life in transitioning to the insulin pump: does prior regimen make a difference?
    Cogen FR; Henderson C; Hansen JA; Streisand R
    Clin Pediatr (Phila); 2007 Nov; 46(9):777-9. PubMed ID: 17585009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
    Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Szypowska A; Lipka M; Błazik M; Golicka D; Groele L; Pańkowska E
    Acta Paediatr; 2009 Mar; 98(3):523-6. PubMed ID: 19046348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive insulin therapy and insulin pumps.
    Bode BW
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Education of the patient for therapy with personal insulin pump].
    Benbenek-Klupa T
    Przegl Lek; 2006; 63(5):292-5. PubMed ID: 17036508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
    Pańkowska E; Szypowska A; Lipka M; Skórka A
    Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Continuous subcutaneous insulin infusion: long-term treatment in an unselected group of insulin-dependent diabetics].
    Waldhäusl W; Freyler H; Bratusch-Marrain P; Vierhapper H; Bruneder H
    Dtsch Med Wochenschr; 1983 Apr; 108(15):570-7. PubMed ID: 6404620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
    Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
    Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
    Pfützner J; Forst T; Butzer R; Forst S; Weber MM; Pfützner AH; Pfützner A
    Diabet Med; 2006 Oct; 23(10):1124-9. PubMed ID: 16978378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump.
    Cohen AW; Liston RM; Mennuti MT; Gabbe SG
    J Reprod Med; 1982 Oct; 27(10):651-4. PubMed ID: 7175835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergent technologies applied to diabetes: what do we need to integrate continuous glucose monitoring into daily practice? Where the long-term use of continuous glucose monitoring stands in 2011.
    Sola-Gazagnes A; Vigeral C
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S65-70. PubMed ID: 22208713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia.
    Lee IT; Liau YJ; Lee WJ; Huang CN; Sheu WH
    J Eval Clin Pract; 2010 Feb; 16(1):202-5. PubMed ID: 20367835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.